Related Experiment Video
Updated: Jun 14, 2025

07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
11.7K
Enabling target-aware molecule generation to follow multi objectives with Pareto MCTS
Yaodong Yang1, Guangyong Chen2, Jinpeng Li1
1Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China.
Communications Biology
|September 2, 2024
Summary
ParetoDrug, a novel algorithm, optimizes multiple drug properties simultaneously for target-aware drug discovery. This approach enhances the generation of effective small-molecule ligands with both strong binding affinity and drug-likeness.
Area of Science:
- Computational chemistry and cheminformatics
- Artificial intelligence in drug discovery
- Molecular modeling and simulation
Background:
- Target-aware drug discovery accelerates the design of small-molecule ligands with high binding affinity.
- Current deep generative models focus on protein-ligand binding but neglect other crucial drug properties like drug-likeness.
- A gap exists in multi-objective optimization for target-aware molecule generation using deep learning.
Purpose of the Study:
- To introduce ParetoDrug, a Pareto Monte Carlo Tree Search (MCTS) algorithm for multi-objective target-aware molecule generation.
- To enable synchronous optimization of multiple molecular properties, including binding affinity and drug-likeness.
- To address limitations of existing methods by incorporating drug-likeness alongside binding affinity.
Main Methods:
- Developed ParetoDrug, a Pareto MCTS generation algorithm for chemical space exploration.
- Utilized pretrained atom-by-atom autoregressive generative models for guided molecule generation within MCTS.
- Introduced the ParetoPUCT scheme to balance exploration and exploitation during atom selection.
Main Results:
- ParetoDrug effectively navigates complex chemical spaces to discover novel compounds.
- The algorithm successfully identifies molecules with satisfactory binding affinities and drug-like properties.
- Demonstrated high effectiveness across various multi-objective target-aware drug discovery tasks through benchmark experiments and case studies.
Conclusions:
- ParetoDrug bridges the gap in multi-objective target-aware molecule generation.
- The proposed method enables simultaneous optimization of binding affinity and drug-likeness.
- ParetoDrug represents a significant advancement in deep learning-based drug discovery for generating effective drug candidates.
Related Concept Videos
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
45
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
45
Multiple Comparison Tests
3.9K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

